KRT1-related diffuse nonepidermolytic keratoderma

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:530838OMIM:600962Q82.8
Who is this for?
Show terms as
8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

KRT1-related diffuse nonepidermolytic keratoderma (also called diffuse nonepidermolytic palmoplantar keratoderma type Unna-Thost, or simply DNEPK) is a rare inherited skin condition caused by changes in the KRT1 gene. This gene provides instructions for making keratin 1, a protein that helps give skin its strength and structure. When this gene does not work properly, the skin on the palms of the hands and soles of the feet becomes abnormally thick, hard, and rough. This thickening is called keratoderma. The main symptom is a diffuse, even thickening of the skin across the entire surface of the palms and soles, usually without blistering. The skin may appear yellowish and feel very tough. Some people also notice that the thickened skin extends slightly onto the tops of the feet or hands. Sweating in these areas can be increased, which may lead to an unpleasant odor or secondary fungal and bacterial infections. There is currently no cure for this condition. Treatment focuses on managing symptoms, mainly by softening and reducing the thick skin using moisturizers, keratolytic creams (products that help break down thickened skin), and careful physical removal of excess skin. With consistent daily skin care, most people can manage their symptoms and live full, active lives. The condition is lifelong but does not affect internal organs or shorten life expectancy.

Also known as:

Key symptoms:

Thick, hard skin on the palms of the handsThick, hard skin on the soles of the feetYellowish or waxy appearance of the thickened skinSkin thickening that covers the entire palm and sole evenlyIncreased sweating on the palms and solesUnpleasant odor from the affected areasSkin that may crack or become painful, especially on the feetIncreased risk of fungal infections (like athlete's foot) in thickened areasMild extension of thickened skin onto the sides of the feet or hands in some peopleDifficulty with fine hand movements due to skin stiffness

Clinical phenotype terms (15)— hover any for plain English
Nonepidermolytic palmoplantar hyperkeratosisHP:0007404Diffuse palmoplantar hyperkeratosisHP:0007447Abnormal umbilicus morphologyHP:0001551OnychomycosisHP:0012203Concave nailHP:0001598Thickened Achilles tendonHP:0004690Decreased movement range in interphalangeal jointsHP:0006203Palmoplantar blisteringHP:0007446Palmoplantar scaling skinHP:0025524Tendon thickeningHP:0032523Knuckle padHP:0032541
Inheritance

Autosomal dominant

Passed on from just one parent; each child has about a 50% chance of inheriting it

Age of Onset

Infantile

Begins in infancy, roughly 1 month to 2 years old

Orphanet ↗OMIM ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for KRT1-related diffuse nonepidermolytic keratoderma.

View clinical trials →

No actively recruiting trials found for KRT1-related diffuse nonepidermolytic keratoderma at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the KRT1-related diffuse nonepidermolytic keratoderma community →

No specialists are currently listed for KRT1-related diffuse nonepidermolytic keratoderma.

View NORD Rare Disease Centers ↗Undiagnosed Disease Network ↗

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to KRT1-related diffuse nonepidermolytic keratoderma.

Search all travel grants →NORD Financial Assistance ↗

Community

Open KRT1-related diffuse nonepidermolytic keratodermaForum →

No community posts yet. Be the first to share your experience with KRT1-related diffuse nonepidermolytic keratoderma.

Start the conversation →

Latest news about KRT1-related diffuse nonepidermolytic keratoderma

No recent news articles for KRT1-related diffuse nonepidermolytic keratoderma.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Questions for your doctor

Bring these to your next appointment

  • Q1.What is the best daily skin care routine for managing the thick skin on my palms and soles?,Which moisturizers or keratolytic creams do you recommend, and how often should I use them?,How can I tell if a skin infection is developing, and when should I seek urgent care?,Should other family members be tested for this condition, and what does a positive result mean for them?,Are there any clinical trials or new treatments being studied that I should know about?,What type of footwear or orthotics would help reduce pain and prevent skin breakdown?,Are there any activities or occupations I should avoid because of this condition?

Common questions about KRT1-related diffuse nonepidermolytic keratoderma

What is KRT1-related diffuse nonepidermolytic keratoderma?

KRT1-related diffuse nonepidermolytic keratoderma (also called diffuse nonepidermolytic palmoplantar keratoderma type Unna-Thost, or simply DNEPK) is a rare inherited skin condition caused by changes in the KRT1 gene. This gene provides instructions for making keratin 1, a protein that helps give skin its strength and structure. When this gene does not work properly, the skin on the palms of the hands and soles of the feet becomes abnormally thick, hard, and rough. This thickening is called keratoderma. The main symptom is a diffuse, even thickening of the skin across the entire surface of th

How is KRT1-related diffuse nonepidermolytic keratoderma inherited?

KRT1-related diffuse nonepidermolytic keratoderma follows a autosomal dominant inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.

At what age does KRT1-related diffuse nonepidermolytic keratoderma typically begin?

Typical onset of KRT1-related diffuse nonepidermolytic keratoderma is infantile. Age of onset can vary across affected individuals.